Neurodegenerative disease
Conditions
Interventions
Case group:None
Control group:None
Sponsors
West China Hospital of Sichuan University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with neurodegenerative diseases who underwent PET imaging in the Department of Nuclear Medicine, West China Hospital, Sichuan University;
Exclusion criteria
Exclusion criteria: Excluding patients with severe physical diseases and a history of neurological and mental disorders, those with any previous brain structural abnormalities (such as brain contusion, intracranial hematoma, depressed or comminuted fractures, diffuse axonal injury, and brain herniation), and those diagnosed with infectious diseases or autoimmune disorders in the recent period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Immune-inflammation biomarkers; | — |
Secondary
| Measure | Time frame |
|---|---|
| Neuroimaging features; | — |
Countries
China
Contacts
Public ContactHongxi Wang
West China Hospital of Sichuan University
Outcome results
None listed